PRMT4 inhibitor TP-064 impacts both inflammatory and metabolic processes without changing the susceptibility for early atherosclerotic lesions in male apolipoprotein E knockout mic... von Zhang, Yiheng, Verwilligen, Robin A.F., de Boer, Miriam, Sijsenaar, Timothy J.P., Van Eck, Miranda, Hoekstra, Menno

Volltext

PRMT3 inhibitor SGC707 reduces triglyceride levels and induces pruritus in Western-type diet-fed LDL receptor knockout mice von de Jong, Laura M., Zhang, Zhengzheng, den Hartog, Yvette, Sijsenaar, Timothy J. P., Martins Cardoso, Renata, Manson, Martijn L., Hankemeier, Thomas, Lindenburg, Peter W., Salvatori, Daniela C. F., Van Eck, Miranda, Hoekstra, Menno

Volltext

Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility von van der Sluis, Ronald J, van den Aardweg, Tim, Sijsenaar, Timothy J. P, Van Eck, Miranda, Hoekstra, Menno

Volltext